GIRFT clinical lead named as dermatology clinician of the year 2024

GIRFT’s clinical lead for dermatology, Professor Nick Levell, has been named as the British Association of Dermatologists’ Clinician of the Year 2024, marking his ongoing contribution to the specialty.

Nick, who was nominated by his colleagues at Norfolk and Norwich University Hospitals NHS Foundation Trust, will be presented with the award at this year’s BAD Annual Meeting in Manchester in July.

Established in 2017, the BAD Dermatology Clinician of the Year Award celebrates a clinical dermatologist who has made a real difference in their local department by going above and beyond. Through their leadership and contributions, award-winners have raised the profile of dermatology, supported colleagues and made improvements to local services.

Nick has been a consultant dermatologist at NNUH for 30 years and is the national specialty lead for dermatology for the National Institute of Health Research (NIHR), and a past president of the BAD.

He was appointed to the GIRFT programme in 2017 and carried out a national review of services across England, conducting meetings with more than 80 dermatology teams. His subsequent GIRFT national report for dermatology (2021) made a series of 23 recommendations aiming to ensure millions of patients with dermatological conditions such as skin cancer, eczema, psoriasis and acne get faster and more equitable access to care.

Alongside Nick’s Clinician of the Year accolade, the BAD has awarded its Sir Archibald Gray Medal 2024, to Dr Tanya Bleiker.

The April edition of the BAD newsletter says: “Many congratulations to Tanya and Nick, who are both worthy recipients of these superb accolades for years of dedicated service to dermatology patients.”

Acknowledging the award, Nick said: “I am delighted, but feel humble and unworthy to have been nominated by my colleagues in Norwich for this award. What we achieve in Norwich is due to many talented, innovative and hardworking administration, nursing and medical superstars. Our team is so very much more than the sum of its parts.”

More updates